CYLD and hepatocellular carcinoma: To date, there is no information about miR-182-mediated Cyld regulation in HCC; here, for the first time, we demonstrated the miRNA–mRNA relationship, providing the basis for the potential use of new anti-miR-182-5p therapeutic approaches in HCC.